|View printer-friendly version|
|August 02, 2001 11:34 a.m.|
|Teva Announces Final Approval of Fluoxetine Oral Solution|
180-Day Market Exclusivity
Jerusalem, Israel, August 2, 2001 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has awarded final approval for fluoxetine oral solution. Launch is anticipated to begin immediately.